tirzepatide and lithium Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials Lilly's weight-loss drug removed from

A European survey to identify challenges in the management of metabolic dysfunction-associated steatotic liver disease

This personalized approach remains valuable even after generics launch, because genetic insights guide dose optimization and compound selection

PEX-168, Polyethylene glycol loxenatide

Abstract Obesity and overweight play an important role in the development of chronic non-communicable diseases, which lead to multiple complications, one of the main ones being cardiovascular diseases, which represent a high mortality rate in the population

Habener served for decades as director of the Laboratory of Molecular Endocrinology at Mass General, where he led pioneering work that uncovered the biology of the glucagon gene and its peptide products

"Think 2025 Was a Big Year for Health News